Status
Conditions
Treatments
About
Subjects will be screened over the phone or in Tufts GYN clinic for participation in the study. If eligible and interested in participating, written informed consent (and assent if applicable) will be obtained. After informed consent/assent, the patient will be enrolled in the study. The patient will decide if they desire to use TENS unit during IUD insertion appointment and inform the study team. The clinic visit will proceed as normal, with additional study proceedings as follows. The study personnel will complete the 'Background Questionnaire' with the patient prior to IUD insertion. During the IUD insertion appointment, study personnel will assist in collection of the 'Study visit' data collection form. This includes recording the patient's pain score at various time points throughout the insertion procedure:
Study personnel will also time the insertion procedure and collect additional data as outlined in the 'Study visit data collection form.' After IUD insertion, the participant will be asked to complete the 'Post-IUD Insertion Survey.' Once this survey is complete, this will conclude the study participation. Participation will last through the study visit only.
As part of the standard of care, a urine pregnancy test will be obtained and confirmed negative prior to IUD insertion. Patients will receive routine pain management modalities per shared decision-making with their clinical provider which may include NSAID administration, paracervical block, and heating pad.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Unable to provide informed consent/assent
Prior cervical procedure (ie loop electrosurgical excision procedure, LEEP)
Concurrent cervical or intrauterine procedure (ie colposcopy or dilation and curettage)
Cutaneous damage at the TENS electrode sites
Chronic or pre-procedure use of opioids
Chronic pain diagnosis
Prior IUD insertion
Any contraindication to intrauterine device (IUD):
Primary purpose
Allocation
Interventional model
Masking
40 participants in 2 patient groups
Loading...
Central trial contact
Caitie McCarthy, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal